Why the study?
Although both human and murine B cells can produce the pleiotropic cytokine interleukin 16 (IL16), its precise role in B cells has remained elusive.
Does IL16 promote the terminal differentiation of B cells into plasma cells?
Does IL16 promote the terminal differentiation of B cells into plasma cells?
IL16 plays a critical role in promoting the terminal differentiation of B cells into plasma cells, independent of its secreted form.
Does not support IL-16 targeting in B-cell disorders; leaves open its role in plasma cell differentiation.
The regulation of terminal differentiation of B cells into plasma cells is influenced by transcription factors, epigenetics, and cytokines. Both human and murine B cells possess the capacity to produce interleukin 16 (IL16), a pleiotropic cytokine that serves as a chemoattractant. Despite its production, the precise role of IL16 in B cells has remained elusive. In this study, we showed that IL16 overexpression promoted primary B cell differentiation into B220 low CD138 + plasma cells. This effect was independent of the secreted form of IL16. The overexpression of IL16 resulted in an increase in the expression of plasma transcription factors Blimp‐1, IRF4, and Xbp‐1, as well as the expression of immunoglobulin genes. Consistently, upon the inoculation of mice with influenza A virus, the absence of IL16 led to a decrease in the number of plasma cells and the production of virus‐specific antibodies. Our data demonstrate that IL16 contributes to the terminal differentiation of B cells to plasma cells.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: